Clinical and laboratory observations in Clostridium difficile colitis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001427:Bacterial Toxins / Q000032:analysis / Q000633:toxicity; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003013:Clostridium / Q000032:analysis; D006224:Cricetinae; D003603:Cytotoxins / Q000032:analysis / Q000633:toxicity; D004195:Disease Models, Animal; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D006168:Guinea Pigs; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D003603:Cytotoxins; D002792:Cholestyramine Resin; D014640:Vancomycin